跳至主要内容
临床试验/JPRN-jRCT2080221648
JPRN-jRCT2080221648未知2 期

Phase 2 Study of SK-1011 - Subfoveal choroidal neovascularization secondary to age-related macular degeneration

SANWA KAGAKU KENKYUSHO CO.,LTD.0 个研究点开始时间: 2011年11月11日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 50age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Age-related macular degeneration patients diagnosed with subfoveal choroidal neovascularization in the study eye
  • 2) Patients who have a BCVA ETDRS score between 73 and 24 letters in the study eye inclusive (approximately 0.5 to 0.06)
  • 3) Patients who are capable of giving written informed consent

排除标准

  • 1) Use of systemic anti-VEGF medication
  • 2) Prior treatment in the study eye with anti-VEGFs, verteporfin, steroids, or laser photocoagulation within certain periods of time
  • 3) Presence of retinal angiomatous proliferation (RAP) in the study eye
  • 4) Medical conditions such as cancer, serious liver, renal cardiac disease

研究者

相似试验